Syncona (LSE:SYNC) Treasury Stock : £0.00 Mil (As of Sep. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Syncona Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Syncona's treasury stock for the quarter that ended in Sep. 2023 was £0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Syncona Treasury Stock Historical Data

The historical data trend for Syncona's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncona Treasury Stock Chart

Syncona Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Treasury Stock

Get a 7-Day Free Trial

Syncona Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Treasury Stock	Get a 7-Day Free Trial															-	-	-	-	-

Syncona Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Syncona (LSE:SYNC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Syncona Ltd (LSE:SYNC) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

SYNCl:UK

Address

8 Bloomsbury Street, 2nd Floor, London, GBR, WC1B 3SR

Website

https://www.synconaltd.com

Syncona Ltd is a closed-ended investment company in the United Kingdom. Its investment objective is to achieve superior long-term capital appreciation from its investments. The company invests in life science businesses (including private and quoted companies) and single or multi-asset projects (Life Science Investments).